ERBB3 and breast carcinoma: Phosphorylation by PKB inhibited the activation of HER2 in breast cancer and resulted in resistance to herceptin;151,152 neural precursor cell expressed and developmentally downregulated 4, an E3 ubiquitin ligase, mediated the degradation of HER3 in prostate cancer through ubiquitination.153